I'm a casual Wikipedia user, so forgive me if this is way off base. The article quotes "The number of deaths is projected to increase due to higher smoking rates and an aging population in many countries", should we also mention the increasing amounts of COPD due to surviving the 9/11 attacks? I just feel like it could be a good addition.
To include this, we would need a very strong secondary source. It bears remembering that "only" at most 100,000 people were exposed to the fumes, which pales in comparison to those exposed to cigarette smoke and smoke from indoor domestic fires. JFW | T@lk 18:03, 7 May 2014 (UTC)
"In 1953, Dr. George L. Waldbott, an American allergist, first described a new disease he named "Smoker's Respiratory Syndrome" in the 1953 Journal of the American Medical Association. This was the first association between tobacco smoking and chronic respiratory disease. "
What do I need to do in order to add information on stem cell therapy to the research section? Ckennerly— Preceding unsigned comment added by Ckennerly (talk • contribs) 14:36, 15 December 2015 (UTC)
You need to use recent high quality sources that are actually about the subject in question. We can than discuss what is a fair summary. Doc James (talk · contribs · email) 18:04, 15 December 2015 (UTC)
Last 3 to 5 years. Than you need to accurately reflect the sources in question. Doc James (talk · contribs · email) 14:12, 16 December 2015 (UTC)
Alright, so for clarification a source between 2010 and 2015 would be acceptable? ckennerly
So Doc James , I just want to be clear, as you've previously stated, I need to use "high quality sources" within the last "3 to 5 years" meaning the oldest source I can use should be no older than 2010.ckennerly
We use the best available sources. There are some rough guidelines on what counts as good.
We discuss it under pathophysiology. Not sure this duplicate content in the section on exacerbation supported by a "letter" is needed.
"Additionally some patients suffer from hyperinflation. These patients are dyspnoeic, with hyperinflated lungs, and without an infectious or eosinophilic pattern. These patients can be treated differently, for instance with longacting bronchodilators. " Using long acting bronchodilators for acute exacerbations of COPD is controversial. Doc James (talk · contribs · email) 21:27, 18 January 2016 (UTC)
Have removed this again as COPD exacerbations are not typically treated with LABAs and the source is a commentary not a review article "although there is reason for longacting bronchodilators as well. " Doc James (talk · contribs · email) 13:36, 19 January 2016 (UTC)
Ref is not saying that long acting agents are appropriate for acute exacerbations but that their long term use can prevent hyperinflation which is somewhat different. Adjusted to reflect Doc James (talk · contribs · email) 00:57, 20 January 2016 (UTC)